KALA Valuation

KALA BIO Inc

Add to Watchlist

Advanced Chart

3.750

+0.030(+0.810%)

Overview
Forecast
Valuation

KALA Relative Valuation

KALA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KALA is overvalued; if below, it's undervalued.

Historical Valuation

KALA BIO Inc (KALA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 8.51. The fair price of KALA BIO Inc (KALA) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：3.75

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.84

P/B

Median3y

0.44

Median5y

1.44

-115.51

FCF Yield

Median3y

-257.64

Median5y

-177.40

Competitors Valuation Multiple

The average P/S ratio for KALA's competitors is 20.94, providing a benchmark for relative valuation. KALA BIO Inc Corp (KALA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap